BRUSSELS, April 20, 2015 /PRNewswire/ -- UCB, a global biopharmaceutical company focusing on neurology and immunology treatment and research, is sponsoring a total of 24 data presentations at the 67th Annual Meeting of the American Academy of Neurology (AAN) in Washington, DC, April 18-25, 2015. Many of the presentations include new data on VIMPAT® (lacosamide) C-V and NEUPRO® (rotigotine).
Help employers find you! Check out all the jobs and post your resume.
